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Paul Abrams, Alan Wein
Urology has seen dramatic changes over the past 20 years. It has moved from an open surgical specialty with few drug treatments to a specialty that has enthusiastically embraced endoscopic (minimally invasive) techniques and new drug treatments for common conditions such as erectile dysfunction and urinary incontinence. The advances that have occurred in the past few years have been mainly in treatment of diseases that are becoming more common as the population ages. These include the two most common urological malignancies, prostate and bladder cancer, as well as lower urinary tract symptoms in older men and urinary incontinence and urinary tract infections, particularly in older women.
Methods
This review concentrates on advances in urology that affect large patient groups and that are having an impact on both community and hospital practice. We have used information gained from attendance at large major urological conferences, which cover all subspecialties within urology, to help select the topics for this article. We also obtained the views of colleagues with subspecialist interests.
Urinary incontinence
There are two main types of urinary incontinence, urge incontinence and stress incontinence. Urge urinary incontinence is due to involuntary contractions of the detrusor muscle during bladder filling, whereas stress incontinence occurs when physical exertion raises the bladder pressure and is due to incompetence of the urethral sphincter mechanism.
Urge urinary incontinence is age related. Bladder training and antimuscarinic drugs remain the principal treatments. Treatment with oxybutynin is often difficult as the dose has to be titrated and it has a high incidence of troublesome side effects. Tolterodine has a similar therapeutic effect but with fewer side effects. Other new preparations such as oxybutynin extended release and propiverine also seem promising. 1 In patients resistant to conservative measures, new surgical techniques such as neuromodulation (bilateral stimulation of sacral (S3) nerve roots) and detrusor myectomy (fig 1) are being used instead of ileocystoplasty, which is a major procedure and produces its own long term problems.
Stress urinary incontinence has become a more common reason for referral as women seek to remain active for longer and often wish to increase their sporting pursuits. Weight reduction, stopping smoking, and pelvic floor exercises should be standard in all women with stress incontinence and will produce satisfactory improvement in 30% of women. 2 The type of surgical repair used to be chosen on the basis of the presumed pathophysiology (suspension for urethral hypermobility and sling for internal sphincter deficiency). Current thinking is that virtually all patients with sphincter incontinence have a combination of the two problems. 3 Suspensions are suitable only for women in whom hypermobility is the primary problem, whereas slings are successful in either group. Two high quality randomised controlled multicentre trials are currently being conducted in the United Kingdom concerning the surgical treatment of stress incontinence. Colposuspension (the open Burch procedure) is being compared with a new suburethral sling procedure (the transvaginal tape) in a Newcastle based study and with laparoscopic colposuspension in a second study organised by the University of Manchester. The first study will shortly report the results of six month follow up. The Manchester study will finish recruiting in early 2001 and report later next year. However, although the early results of surgical treatment for stress incontinence are often promising, the effects after two years can be disappointing. Longer follow up for all trials is therefore essential.
The management of incontinence has been defined by new clear algorithms. 4 The first step is to ensure that each patient receives a proper structured initial evaluation by appropriately trained staff. This principle is also endorsed in the Department of Health's recent publication Good Practice in Continence Services. 5 Urinary incontinence is very common, but most people do not desire or require radical treatment. The first international consultation on incontinence, sponsored by the World Health Organization, emphasises the value of non-medical, non-surgical treatments such as bladder training for urge incontinence and pelvic floor rehabilitation for stress incontinence. The consultation used a "quasi Cochrane" approach to analyse the evidence for its recommendations. 6
Older men with lower urinary tract symptoms
The nomenclature used to describe this group of patients has changed. 7 The most recent WHO sponsored consultation held in Paris in 2000 recommended that as well as lower urinary tract symptoms the terms benign prostatic enlargement and bladder outlet obstruction should become standard. Benign prostatic hyperplasia will then be used exclusively to describe the characteristic histological picture. 8 Lower urinary tract symptoms suggestive of bladder outlet obstruction are usually treated empirically in primary care, and two effective classes of drugs are now available. The new adrenergic antagonists, tamsulosin and alfuzosin, produce fewer side effects than previous drugs in the same group. 9 Finasteride (a 5-reductase inhibitor) has been shown to reduce the size of large prostates (volume > 40 cm 3 ), although it takes six to eight months to produce its full effect. 9 It provides some protection against the complications of bladder outlet obstruction, including acute retention. 10 In surgery, interest has focused on the use of less invasive procedures that cause less morbidity than transurethral resection of prostate. Numerous techniques that aim to destroy prostatic tissue by heat-for example, by laser, vaporisation, radio frequency, or ultrasound-have been and are being evaluated, but insufficient data are available from randomised controlled trials to determine whether they are cost effective and produce sustained benefit. Traditional transurethral resection uses cautery, and new methods of incising prostatic tissue are now being evaluated that may have advantages, including reduced blood loss. 11 The holmium yttrium-aluminium-garnet laser technique is the closest to traditional transurethral resection in that it removes tissue under endoscopic control. This is now a recommended surgical technique. 12 However, traditional transurethral resection by an experienced surgeon with modern equipment is highly effective and safe.
Oncology
Prostate cancer is increasingly detected at an earlier stage by serum measurement of prostate specific antigen. 13 Although prostate specific antigen is probably the best available blood test for detecting any cancer, it still has somewhat limited specificity and sensitivity. Its value has been improved by techniques such as monitoring change in concentration with time (velocity), assessing concentration in relation to prostate volume and to age, and, most recently, measuring the free to total prostate specific antigen ratio (the lower the ratio the greater the chance of prostate cancer being detected by biopsy). Controversy continues about the treatment of apparently localised prostate cancer. However, radical treatment is generally not justified in patients with a prostate specific antigen concentration over 20 g/l, as the tumour will often extend beyond the prostatic capsule. 14 The grade of tumour and the life expectancy of the patient also influence the final decision. Patients with well differentiated tumours may do well without treatment, whereas those with poorly differentiated tumours usually do badly. Most men have moderately well differentiated tumours and are likely to benefit from radical treatment if they have a life expectancy of more than 10 years.
Radical prostatectomy has two important complications: incontinence and impotence. A new method of radical prostatectomy by laparoscopy seems to reduce morbidity and hospital stay. 15 The complications of radical prostatectomy have prompted the use of new types of brachytherapy; transperineal implantation of radioactive iodine or palladium seeds has attracted great publicity, particularly in the United States. 16 However, the technique is not being evaluated in a randomised controlled trial to determine whether it is better than watchful waiting. 17 The NHS is currently funding a trial in three British centres on the feasibility of mounting a randomised controlled study of treatments for early prostate cancer. The rubber shod clamp holds the extraperitoneal tissues while a Babcock forceps holds the detrusor muscle, which has been dissected from the underlying urothelium. The urothelium with its own blood supply appears blue owing to methylene blue in the bladder
Endo-urology
New instruments such as the flexible ureterorenoscope have made it possible to inspect the whole of the urinary tract, from kidney to urethra, via the urethra. Many kidney conditions can now be treated less invasively by a percutaneous approach through the loin, retrograde approaches through the urethra, bladder, and ureter, or laparoscopy. Almost all patients with upper urinary tract stones can now have them removed endoscopically or by lithotripsy (box). 18 Endoscopic techniques are also used in combination with other new technologies. Lasers applied through ureteroscopes and cystoscopes can be used to destroy transitional cell carcinomas in both the upper and lower urinary tracts as well as to disintegrate urinary tract stones. Many of these procedures can now be performed as day cases, often under local anaesthesia.
Improved and earlier imaging with ultrasonography, computed tomography, or magnetic resonance imaging has resulted in early diagnosis of relatively small renal cell carcinomas. Laparoscopic surgery is being evaluated to assess whether it has equivalent disease free survival to open surgery with fewer complications and reduced morbidity and costs. A similar analytical approach is needed to assess whether laparoscopic transplant nephrectomy, now common in the United States, should be used more widely.
Endo-urology is costly in terms of both staff and equipment. New techniques must therefore be shown to produce benefits for both patients (reduced morbidity) and society (reduced costs) before being widely used.
Andrology
Much has been written about sildenafil, which has revolutionised the treatment of erectile dysfunction. However, in some countries, including the United Kingdom, the cost of sildenafil is not reimbursed by the state for most men with erectile dysfunction. General practitioners in the United Kingdom can now prescribe the drug privately, and several guidelines have been produced to inform and educate general practitioners about the investigation and treatment of erectile dysfunction (www.bui.ac.uk). 19 Insertion of penile prostheses is still required for men in whom sildenafil is ineffective and who do not respond to or dislike intracavernosal injections or vacuum devices, particularly men with diabetes, cardiovascular disease, or neurological disease (fig 2) . Surgical treatment may also be required in some patients with Peyronie's disease.
Paediatric urology
In the United Kingdom the emergence of clinical governance is greatly changing paediatric urology. For example, surgical management of the rare condition bladder exstrophy will be concentrated in two centres. This is important as surgery for exstrophy still leaves many patients with continence and sexual problems. 20 Some advances have brought almost as many problems as they solve: the advent of prenatal ultrasonography has led to the diagnosis of spina bifida, hydronephrosis, urethral valves, oligohydramnios, and even bladder exstrophy before birth. Many parents elect to have the pregnancy terminated if the prenatal diagnosis suggests a poor prognosis. The accuracy of the diagnosis is often uncertain, particularly in terms of predicting renal function. Prenatal insertion of vesicoamniotic shunts in babies with urethral obstruction may benefit some, but often the degree of renal dysplasia means that intervention is unhelpful. The diagnosis of unilateral hydronephrosis means that the pregnancy is surrounded by uncertainty for the parents, and the postnatal investigations of the baby sometimes turn out to be unnecessary. 21
Looking to the future
The evidence base relating to recent advances in urology is deficient in several respects. Little information is available on cost effectiveness or the effect on quality of life. Randomised controlled trials are the best way to assess new methods of management. New drugs have to be evaluated in randomised controlled trials, and the appropriate authorities monitor any developments. However, devices and new surgical techniques can be introduced without evidence of efficacy in many parts of Europe. Governments should insist that, after brief pilot studies, new devices and treatments are available only within randomised controlled trials until they are shown to be effective, safe, and cost effective in the widest sense. However, responsiveness and funding are important obstacles to this goal. Most countries are reducing government funding for the assessment of technological developments in medicine, making researchers ever more reliant on commercial financial support. We hope that this process can be re-evaluated so that in future genuine advances in urology can be developed and made available to patients as rapidly as possible.
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Online resources
British Association of Urological Surgeons: www.baus.org.uk The principal organisation in the UK for urological surgeons; the site lists all major national and international meetings and deals with continuing urological education Bristol Urological Institute: www.bui.ac.uk Contains reviews, urological guidelines for general practice, and information on the institute's courses and meetings Uroweb: www.uroweb.org Displays poster presentations, has a comprehensive slide and literature library, and highlights congress information and subspecality presentations and reviews Continence Foundation: www.continence-foundation.org.uk Provides information for the public on symptoms, treatments, products, publications, and organisations as well as specific pages for healthcare professionals US National Institutes of Health-Urology Section: www.niddk.nih.gov/health/urolog/urolog.htm Displays statistical information; contains online easy to read publications (in Spanish as well as English) American Urological Association: www.auanet.org
Information on major international meetings, as well as information for patients and the media, available through Uromart, which displays news on how and where to buy urological products

One hundred years ago Medical Interests in the General Election
Lord Rosebery, when he went on board the Liberal boat last Monday with Captain Lambton, and nailed his colours to the mast, enumerated as the "three great national reforms which cannot wait: Legislation in respect of temperance, the housing of the working classes-not on extreme and visionary, but on sound and practical lines-and fearless administrative reform, more especially of the War Office." Upon certain aspects, at least, of all these reforms the medical profession can speak with authority, and the present moment is opportune for the exercise of personal influence to impress on those who aspire to Parliamentary honours the importance of the medical questions involved. The mind of the candidate, if it is not altogether wax in the hands of electors whom he hopes to represent, is at least more ductile than it is apt to become when he is entitled to write after his name the magic letters M.P.
Upon the reforms which stand second and third on Lord Rosebery's list, the opinion of the profession has been expressed pretty fully and definitely. Whenever the broader sanitary problems of the day are studied, whether it be the prevention of zymotic diseases or of tuberculosis, the diminution of the terrible infantile mortality which now prevails, or the means for checking the increase of insanity, we invariably, when we attempt to probe the matter to the bottom, come down to the fact that the overcrowded tenements of great cities and the dilapidated, ill-ventilated cottages of the country villages are the main obstacles in the way of fundamental improvement.
As to administrative reform, the medical profession has time out of mind urged that there should be a Minister of Public Health, who should be directly responsible to Parliament. Under the present system, or want of system, there is no central Public Health office to deal with such questions as the prevention of the introduction of plague, and other zymotic diseases, into the United Kingdom; or to conduct negotiations with foreign Governments on such matters. The Local Government Boards in England, Scotland, and Ireland, the Privy Council Office, the Home Office, the Board of Trade, the War Office, the Foreign Office, the India Office, and even the Colonial Office, all have their fingers in the pie, but no one Minister is responsible. (BMJ 1900; ii:939.) 
